<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib53">
 <label>53</label>
 <element-citation publication-type="book" id="sref53">
  <source>Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulseÂ® Inhaled Nitric Oxide Therapy to Treat COVID-19</source>
  <year>May 11, 2020</year>
  <publisher-name>Globe Newswire</publisher-name>
  <ext-link ext-link-type="uri" xlink:href="http://www.globenewswire.com/news-release" id="intref0015" xmlns:xlink="http://www.w3.org/1999/xlink">www.globenewswire.com/news-release</ext-link>
 </element-citation>
</ref>
